The uncertainty of what a post healthcare reform landscape will look like in the United States is not deterring companies from other countries from pitching for business. At a conference hosted by the America-Israel Chamber of Commerce with the Jefferson School of Population Health at Thomas Jefferson University in Philadelphia, 11 health IT and healthcare technology companies made a case for regional healthcare companies to adopt their software systems and applications and for investors to park their capital with them.
Many of the companies presenting already have established partnerships with healthcare providers in the country such as Mediviz Systems and Safend. On the other end of the scale, CureMyWay is an early stage start-up seeking $1 million to $2 million of investment for a digital health platform to help people make informed decisions about their care.
The companies’ capabilities covered a variety of areas including how to reduce the time involved searching electronic medical records for proper candidates for a clinical trial (Cliniworks) to imaging technology in a home monitoring setting that dispenses with radiation, relying instead on vibrations from lung sounds to generate Vibration Response Imaging (Deep Breeze).
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Dr. David Nash, the Dean of the Jefferson School of Population Health, is also is a professor of health policy and shared his perspective of the event.
Mediviz Systems’ software manages the schedules of a healthcare facility’s surgery by responding to changes prompted by patient conditions pre-surgery or the time it takes for surgery to be performed. OR-flow uses a touchscreen so that clinical coordinators can help optimize the schedule. The ompany’s software was first deployed at Cedar Sinai Medical Center in 2010 using matching funds from the BIRD Foundation, a group that facilitates partnerships between Israeli and American companies. Arieh Dranger is a co-founder of the company. Its headquarters are in Los Angeles, but its R&D facility is based in Rehovat, Israel.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
MedCPU tackles the need for unifying disparate sources of information, be they from physicians’ and nurses’ handwritten notes on a patient’s chart, and data from other IT systems to activate clinical alerts and prompts. Its first application has been for obstetrics. Dr. Eyal Ephrat is the CEO.
One issues that repeatedly comes up with electronic medical records is the issue of data protection. Safend, based in Tel Aviv with a U.S. office in Philadelphia, focuses on data protection concerns such as preventing data loss and theft from companies to mapping and controlling the flow of data through e-mail, the Internet and other channels. Jay Smilyk is the vice president of sales for the Americas.
Efficiency and reducing administrative costs are some of the big catchwords health IT companies frequently cite in their spiel. Tayla Miron-Shatz, the co-founder and CEO of CureMyWay, presented a customer-oriented tool to help consumers make medical decisions in a more efficient manner — for example, deciding whether they should have elective surgery to improve the quality of their lives. The early stage start-up is in the research stage of its development.
